Lucy Scientific Discovery, Inc.

Not Rated
  • Market Cap: N/A
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: CA54960E1043
USD
0.00
0.00 (0.00%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationCash Flow
Lucy Scientific Discovery, Inc. Cash flow Statement
Figures in Million
Consolidated Cash Flow Results
Jun'23
Jun'22
Jun'21
Jun'20
No of Months
12
12
12
12
Profit Before Tax
-8.00
-5.00
-4.00
-3.00
Adjustment
0.00
0.00
0.00
0.00
Changes In working Capital
0.00
0.00
0.00
0.00
Cash Flow after changes in Working Capital
0.00
0.00
0.00
0.00
Cash Flow from Operating Activities
-4.00
-2.00
-1.00
0.00
Cash Flow from Investing Activities
0.00
0.00
0.00
0.00
Cash Flow from Financing Activities
6.00
2.00
1.00
0.00
Net Cash Inflow / Outflow
1.00
0.00
0.00
0.00
Opening Cash & Cash Equivalents
0.00
0.00
0.00
0.00
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0.00
0.00
0.00
0.00
Cash & Cash Equivalent of Subsidiaries under liquidations
0.00
0.00
0.00
0.00
Translation adjustment on reserves / op cash balances foreign subsidiaries
0.00
0.00
0.00
0.00
Effect of Foreign Exchange Fluctuations
0.00
0.00
0.00
0.00
Closing Cash & Cash Equivalent
0.00
0.00
0.00
0.00
Figures in USD Million
Seasonal companies are compared with the same quarter last year
Compare Cash Flow Results of Lucy Scientific Discovery, Inc.
Markets Mojo
Figures in Million
consolidated Cash Flow Results
Markets Mojo
Markets Mojo
Change(USD)
Change(%)
Profit Before Tax
-8.98845600006032
-13.162
5.00
31.71%
Adjustment
0
0
0.00
0.00%
Changes In working Capital
0.142724000000958
0.828
0.00
-82.76%
Cash Flow after changes in Working Capital
0
0
0.00
0.00%
Cash Flow from Operating Activities
-4.26635300002863
-12.904
8.00
66.94%
Cash Flow from Investing Activities
-0.265894000001784
12.893
-12.00
-102.06%
Cash Flow from Financing Activities
6.19228800004156
2.976
4.00
108.07%
Net Cash Inflow / Outflow
1.62049500001088
2.965
-1.00
-45.35%
Opening Cash & Cash Equivalents
0
0
0.00
0.00%
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0
0
0.00
0.00%
Cash & Cash Equivalent of Subsidiaries under liquidations
0
0
0.00
0.00%
Translation adjustment on reserves / op cash balances foreign subsidiaries
0
0
0.00
0.00%
Effect of Foreign Exchange Fluctuations
-0.0395460000002653
0
0.00
0.00%
Closing Cash & Cash Equivalent
0
0
0.00
0.00%
Cash Flow - Snapshot (Consolidated) - Jun'23
stock-summary

YoY Growth in year ended Jun 2023 is -76.41% vs -62.90% in Jun 2022

Jun'23
Jun'22
Change(%)
Cash Flow from Operating Activities
-4.27
-2.42
-76.41%